This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes U.S. phase II, III, and IV overactive bladder trials that are currently recruiting participants as well as phase II BPH trials. This list is current as of Feb. 16, 2011.
Overactive Bladder
• Combined Behavioral and Drug Treatment of OAB in MenSponsor(s): University of Alabama at Birmingham
Identifier: NCT01175382
• Hypnotherapy for Treatment of OABSponsor(s): University of New Mexico
Identifier: NCT00793611
• Solifenacin Succinate (VESIcare) for the Treatment of OAB in Parkinson's DiseaseSponsor(s): University of South Florida, Astellas Pharma Inc.
Identifier: NCT01018264
• Local Anesthetic Treatments for OABSponsor(s): NorthShore University HealthSystem Research Institute, Berlex Foundation
Identifier: NCT00427648
• A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive BladderSponsor(s): Pfizer
Identifier: NCT00928070
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.
Malpractice Consult: How likely are you to face a medical malpractice lawsuit?
July 23rd 2024"Although there is a good chance that you will face allegations of medical negligence at some point in your career, it is unlikely that you will ever be found liable by a jury," writes Victoria L. Neikam, Esq.